Mufg Securities (Canada), Ltd. Bausch Health Companies Inc. Transaction History

Mufg Securities (Canada), Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$21.6 - $27.79 $3.32 Million - $4.27 Million	-153,693 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$23.0 - $29.01 $1,058 - $1,334	46 Added 0.03%	153,693 $4.25 Million
Q3 2021 Nov 05, 2021	SELL	$25.04 - $30.06 $271,058 - $325,399	-10,825 Reduced 6.58%	153,647 $4.29 Million
Q2 2021 Aug 06, 2021	BUY	$27.43 - $32.7 $246 - $294	9 Added 0.01%	164,472 $4.83 Million
Q1 2021 May 06, 2021	BUY	$21.37 - $34.38 $705 - $1,134	33 Added 0.02%	164,463 $5.21 Million
Q4 2020 Mar 09, 2021	BUY	$15.31 - $21.12 $2.52 Million - $3.47 Million	164,430 New	164,430 $3.41 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.78B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Mufg Securities (Canada), Ltd., based on Form 13F filings with the SEC.

Stay updated on Mufg Securities (Canada), Ltd. with notifications on news.